Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
discover how we can advance health together. Duke Health Integrated Practice https://careers.dukehealth.org/us/en/dhip Duke Health Integrated Practice comprises more than 110 primary and specialty outpatient
-
University of North Carolina at Chapel Hill | Chapel Hill, North Carolina | United States | 5 days ago
cancer immunotherapy program focused on advancing AI-designed cancer vaccines and immunotherapies from discovery through clinical translation. Reporting to the Director of Clinical and Translational
-
University of North Carolina at Chapel Hill | Chapel Hill, North Carolina | United States | about 6 hours ago
leadership for a multi-year cancer immunotherapy program focused on advancing AI-designed cancer vaccines and immunotherapies from discovery through clinical translation. Reporting to the Director of Clinical
-
the EU Research Framework Programme? Not funded by a EU programme Is the Job related to staff position within a Research Infrastructure? No Offer Description https://www.unimib.it/ateneo/gare-e-concorsi
-
announced for the awarding of no. 1 Research Assignment titled: “Clinical and Translational Research in Multiple Myeloma: Novel Immunotherapies, Prognostic Biomarkers and Precision Medicine”, aimed
-
Università degli Studi di Roma Tor Vergata - Dipartimento di Medicina Sperimentale | Italy | 13 days ago
, and precision in executing immunoassays. Where to apply Website https://pica.cineca.it/uniroma2/ Requirements Additional Information Eligibility criteria Eligible destination country/ies for fellows
-
“Prediction of response to immunotherapy in melanoma using metabolic signatures of the gut mycobiome”, funded by National Science Centre. Where to apply Website https://system.erecruiter.pl/FormTemplates
-
cancer immunotherapies. The project aims to understand how the diverse immune cells in the tumor microenvironment drive response or resistance to immunotherapy in lymphomas, using methods such as spectral
-
responses to immunotherapy may serve as a source of immunomodulatory molecules capable of reversing T cell exhaustion within the tumor microenvironment. Through aptamer-based screening, multi-omics
-
-microenvironment responses, and investigate how these drugs can improve treatment when combined with standard-of-care therapies and immunotherapy. Postdoctoral Researcher – Preclinical Cancer Drug Development Our